Literature DB >> 34935610

Diabetes Insipidus Should Be Included.

Werner A Scherbaum.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34935610      PMCID： PMC8727862          DOI： 10.3238/arztebl.m2021.0312

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  3 in total

1.  Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy.

Authors:  Maria V Deligiorgi; Gerasimos Siasos; Chrysovalantis Vergadis; Dimitrios T Trafalis
Journal:  Int Immunopharmacol       Date:  2020-03-31       Impact factor: 4.932

2.  Anti-PD-L1 Treatment Induced Central Diabetes Insipidus.

Authors:  Chen Zhao; Sri Harsha Tella; Jaydira Del Rivero; Anuhya Kommalapati; Ifechukwude Ebenuwa; James Gulley; Julius Strauss; Isaac Brownell
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

3.  The Diagnosis and Management of Endocrine Side Effects of Immune Checkpoint Inhibitors.

Authors:  Knut Mai; Martin Fassnacht; Dagmar Führer-Sakel; Jürgen B Honegger; Matthias M Weber; Matthias Kroiss
Journal:  Dtsch Arztebl Int       Date:  2021-06-11       Impact factor: 5.594
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.